You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Chronic Pain and Safe Opioid Prescribing

The ACP Advance Chronic Pain program aims to spread quality improvement strategies that improve primary care chronic pain management, safe opioid prescribing practices, and substance use disorder prevention, treatment, and recovery.

Resources provided through this program are designed to help you:

  • Understand QI and practice transformation methodology
  • Understand evidence-based strategies for effective management of chronic pain in primary care, including assessment and management of psychological comorbidities
  • Develop an action plan to support improved care of patients with chronic pain
  • Describe evidence-based tools to assess patient risk for opioid use disorder
  • Identify resources for prevention, treatment, and recovery of opioid use disorder

As part of this work, ACP has partnered with the American Academy of Addiction Psychiatry (AAAP) and a coalition of national professional organizations on two SAMHSA-funded initiatives, the Provider Clinical Support System (PCSS)1 and Opioid Response Network (ORN)2 programs to combat the opioid crisis.

Wondering Where to Start?

Take this practice assessment survey to assist you in pinpointing key areas for improvement in your clinical setting and identifying strategies to increase your adult immunization rates.

Take Survey!

QI Resources

ACP Advance QI Curriculum – offers a practical, step-wise approach that guides you through each stage of the QI journey from establishing the “what” and “why” for change to implementing and sustaining change. CME/MOC credit is available for physicians who complete this online curriculum.

QI Videos

In these videos, Drs. Matthew Bair and Gregory Hood a brief overview of key topics related to effective chronic pain management in primary care, followed by an example of how to implement a QI project in your practice related to these topics.

Pain and Mental Health Assessments — Matthew Bair, MD, MS, FACP

Minimizing Risk of Abuse — Gregory Hood, MD, MACP, FRCP

Controlled Substance Agreements — Gregory Hood, MD, MACP, FRCP

Webinars

ACP Advance: Chronic Pain and Substance Use Disorder Management - Gregory A. Hood, MD, MACP, FRCP; Matthew J. Bair, MD, MS, FACP; Kathryn L. Cates-Wessel, CEO, American Academy of Addiction Psychiatry

Chronic Pain & Opioid Addiction: Clinical Challenges and Management Strategies - Daniel P. Alford, MD, MPH, FACP

Pain and Mental Health Assessments in Primary Care - Matthew Bair, MD, MS, FACP
Learn about factors related to a comprehensive pain assessment and some common screening tools helpful in assessing pain.

Pain Contracts and Risk Assessments - Dr. Gregory Hood, MD, MACP, FRCP PI, Kentucky ACP Pain QI Study

Online Learning Center Resources

Visit ACP’s Online Learning Center to access many educational resources related to Chronic Pain Management.

Online Learning Center

Patient Education Materials

Chronic Pain – Patient FACTS
English | Español

Chronic Pain: Creating a Plan with your Health Professional – Video

ACP Publication: Enhancing the Safe and Effective Management of Chronic Pain in Accountable Care Organization Primary Care Practices in Kentucky

External Resources

Providers Clinical Support System — PCSS was funded by SAMHSA to provide training and mentoring at NO COST to health professionals in evidence-based practices in the prevention, identification and treatment of substance use disorders with a focus on opioid use disorders. 

Opioid Response Network — The mission of the ORN is to provide training and technical assistance via local experts to enhance prevention, treatment (especially MAT with buprenorphine, naltrexone, and methadone), and recovery efforts across the country addressing state and local specific needs.

Support for ACP’s Chronic Pain initiative is provided by the Substance Abuse and Mental Health Association (SAMHSA), Pfizer, Inc., and Teva Pharmaceuticals.

1Funding for this initiative was made possible (in part) by grant no. 5U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

2Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.